Ontogeny of equine haemoglobins.

This research article investigates the oxygen-binding capacities of fetal and maternal haemoglobins in horses, finding a relation with levels of 2,3-diphosphoglycerate, a compound that regulates hemoglobin’s oxygen affinity, in red blood cells.

Plain Language Overview

The research focused on studying how efficiently fetal and maternal hemoglobin in horses can bind with oxygen. The study discovered that level of efficiency was linked to the levels of 2,3-diphosphoglycerate in the red blood cells, a substance that helps manage the ability of hemoglobin to bond with oxygen.

Study Focus: Hemoglobin Affinity for Oxygen

• The primary focus of the research revolves around understanding the oxygen-binding affinity of fetal and maternal hemoglobin in horses.
• Hemoglobin, the protein in red blood cells, has the vital function of carrying oxygen from the lungs to the body’s tissues.
• The efficiency with which hemoglobin can bind with oxygen and release it where needed is a critical factor in the overall oxygen supply of an organism.

The Role of 2,3-diphosphoglycerate

• The study particularly looked into the relation of oxygen-binding efficiency in hemoglobin with the levels of the compound 2,3-diphosphoglycerate.
• 2,3-diphosphoglycerate, also known as 2,3-DPG, is a compound found in red blood cells that acts as a regulator of hemoglobin’s ability to bind with oxygen.
• Higher levels of 2,3-DPG tends to lower hemoglobin’s affinity for oxygen, making the oxygen release to tissues more efficient.

Finding Correlations

• Through this research, correlations were found between the oxygen-binding efficiencies of fetal and maternal hemoglobin and the erythrocytic levels of 2,3-DPG.
• This finding implies that the levels of 2,3-DPG, and consequently its regulatory effect on hemoglobin, may differ between foetal and maternal organisms, affecting their respective oxygen supply efficiencies.